National University Heart Centre, Singapore (NUHCS)
Singapore, 119074
Location status: Recruiting
NCT Number: NCT07421882
The PRE-hospital Cooling to improvE carDiac arrEst Neurological outComEs (PRECEDENCE) study is a pilot feasibility trial evaluating the implementation of pre-hospital targeted temperature management (TTM) using a wearable surface cooling device (CarbonCool® vest) in adult out-of-hospital cardiac arrest (OHCA) patients with return of spontaneous circulation (ROSC). The study aims to assess feasibility, fidelity, acceptability, and safety of initiating cooling in the field by emergency medical services (EMS) prior to hospital arrival. Results will inform the design of a larger definitive trial to determine the clinical effectiveness of early pre-hospital TTM in improving neurological outcomes.
Interested in participating?
Request Info16 year–80 year
All sexes
Interventional
Not applicable
Singapore, 119074
Location status: Recruiting
Background: Despite advances in resuscitation, neurological recovery after out-of-hospital cardiac arrest (OHCA) remains poor. Current hospital-initiated targeted temperature management (TTM) often begins several hours after ROSC, potentially missing the optimal neuroprotective window. Early or ultra-early cooling during the pre-hospital phase may mitigate ischemia-reperfusion brain injury, but evidence from real-world EMS settings is limited.
Rationale: The PRECEDENCE study tests the operational feasibility of initiating TTM in the pre-hospital environment using a novel, power-free CarbonCool® cooling vest designed for rapid application by paramedics immediately after ROSC. The vest provides conductive surface cooling without interfering with resuscitation, transport, or diagnostics.
Study Design: PRECEDENCE is a pilot feasibility trial conducted by the Singapore Civil Defence Force (SCDF) and collaborating hospital. Eligible OHCA patients attended by SCDF Division 4 paramedics will be allocated to either (a) pre-hospital TTM using the CarbonCool® vest or (b) standard pre-hospital care, depending on predefined eligibility and operational criteria. Both groups will be prospectively followed through hospital discharge.
Outcomes: The primary outcome is feasibility of implementing pre-hospital TTM, evaluated through recruitment rates, intervention delivery, protocol fidelity, and provider acceptability. Secondary outcomes include hospital TTM uptake, time from ROSC to target temperature, neurological outcome at discharge (CPC 1-2), and predefined safety endpoints (overshoot cooling < 33 °C, hemodynamically significant bradyarrhythmias, and skin injury).
Significance: By assessing real-world feasibility and safety of early pre-hospital cooling, this pilot will provide critical implementation data and guide protocol refinements for a future multi-division or national randomized trial.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The CarbonCool® vest is a power-free, thermoplastic polyurethane (TPU) surface cooling device containing a proprietary carbon-based cooling medium capable of high heat exchange (35 W/mK). It is designed for rapid pre-hospital application and continuous cooling during patient transport.
Time frame: Through study completion, anticipated to be one year
Proportion of EMS-attended, eligible OHCA patients who received pre-hospital TTM
Time frame: Through study completion, anticipated to be one year
Proportion of recruited OHCA patients receiving the TTM protocol as intended
Time frame: Through study completion, anticipated to be one year
Adherence of paramedics to workflow and case report forms
Time frame: Time frame within 3 months of case recruitment
Paramedic acceptability of the intervention will be assessed using the validated Acceptability of Intervention Measure (AIM). The AIM consists of a 4-item questionnaire rated on a 5-point Likert scale, with higher scores indicating greater acceptability of the intervention. Range score between 4 to 20.
Time frame: Time frame within 3 months of case recruitment
Perceived appropriateness of the intervention will be evaluated using the validated Intervention Appropriateness Measure (IAM). The IAM is a 4-item questionnaire rated on a 5-point Likert scale, with higher scores indicating greater perceived fit and relevance of the intervention for prehospital care. Range score between 4 to 20.
Time frame: Time frame within 3 months of case recruitment
Feasibility of implementing the intervention in the operational prehospital setting will be assessed using the validated Feasibility of Intervention Measure (FIM). The FIM comprises 4 items rated on a 5-point Likert scale, with higher scores indicating greater perceived feasibility. Range score between 4 to 20.
Time frame: 6 hours
Percentage of out-of-hospital cardiac arrest (OHCA) patients who meet inclusion criteria and subsequently receive targeted temperature management (TTM) in hospital.
Time frame: 12 hours
Duration (in minutes) from return of spontaneous circulation (ROSC) to achievement of target core temperature
Time frame: To hospital discharge, with an average of 30 days
Proportion of patients with a Cerebral Performance Category (CPC) score of 1 or 2 at hospital discharge.
Time frame: 72 hours
Number and proportion of patients with a core temperature drop below 33°C during surface cooling in the Coronary Care Unit (CCU).
Time frame: 72 hours
Number and proportion of patients experiencing clinically significant bradyarrhythmias (requiring intervention or causing hemodynamic instability).
Time frame: 72 hours
Number and proportion of patients with skin injury (e.g., erythema, blister, burn) attributed to use of the surface cooling device.
Contact information is provided by the study sponsor or research team.
Singapore General Hospital
Other
PRE-hospital Cooling to improvE carDiac arrEst Neurological outComEs (PRECEDENCE): a Pilot Feasibility Study
Acronym: PRECEDENCE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03700125
Arrhythmias, Cardiac, Cardiopulmonary Arrest With Successful Resuscitation
London, United Kingdom
View Trial DetailsNCT01789554
Arrhythmias, Cardiac, Cardiovascular Diseases
Stockholm, Stockholm County, Sweden
View Trial DetailsNCT03981107
Cardiac Arrest, Cardiopulmonary Resuscitation
Bergamo, Italy
View Trial DetailsNCT06805344
Arrhythmias, Cardiac, Cardiac Arrest
View Trial Details